Andrew Chung
Founder & Managing Partner
Andrew has spent over 25 years identifying breakthrough science early and building the companies that bring it to market. His track record includes early involvement in category-defining companies such as QuantumScape, Natera, Impossible Foods, Personalis, Wattpad, LanzaTech, Orbis Education, Solazyme, and Nest—collectively representing over $30 billion in value creation across energy, healthcare, and advanced technologies.
Andrew is an Executive Fellow in Venture Translation & Innovation at Harvard’s Institute for Quantitative Social Sciences and serves on the Dean’s Cabinet at the Harvard John A. Paulson School of Engineering and Applied Sciences. Over the past several years, he has worked directly with Harvard research laboratories to develop translational ventures from the earliest stages of scientific discovery.
Prior to founding 1955 Capital, Andrew was a General Partner at Khosla Ventures and an investor at Lightspeed Venture Partners, where he helped build leading deep technology investment practices. He has served as a director or advisor to more than 20 companies, and has led cross-border initiatives in Asia, including participation in the 2014 U.S.–China Presidential Trade Mission.
Earlier in his career, Andrew invested at Bain Capital and TL Ventures, and worked as a consultant at Bain & Company. He holds a BA in Applied Mathematics from Harvard University and an MBA from the Wharton School.
Outside of investing, Andrew is an avid musician who has performed at Lincoln Center, the Kennedy Center, and the Shanghai Conservatory—and a ski mountaineer and IFSA-certified ski coach who trains his daughter, a North American junior freeride champion.
1955 PORTFOLIO
Nature’s Fynd (alternative proteins)
Noah Medical
(surgical robotics)Ampaire
(electric aviation)Gridtential
(energy storage)Crop Enhancement (agriculture)
LINKS